MTCR实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (21 Jun 2023 @ 03:11):

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases...

Stats
今日成交量	83 889
平均成交量	52 473
市值	25.48M
EPS	$-0.130 ( Q3 \| 2022-11-14 )
Last Dividend	$0.580 ( 2023-06-21 )
Next Dividend	$0 ( N/A )
P/E	-0.564 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0160 (2.75%)

AADI -3.24%

ABCL 2.01%

ABCM 0.04%

ABEO -2.61%

ABIO -3.73%

ABOS 0.70%

ABSI 2.04%

ABUS -1.81%

ABVX -1.50%

ACAD -0.54%

ACER -17.95%

ACET -4.76%

ACGN 1.29%

ACHL -4.11%

ACHV -0.22%

ACIU -0.75%

ACLX 0.73%

ACRV -2.31%

ACST -2.90%

ACXP 1.38%

ADAG 4.64%

ADAP -4.01%

ADGI 0.87%

ADIL 1.75%

ADMA -2.14%

ADPT 0.15%

ADTX -2.08%

ADVM -3.33%

ADXN -1.60%

AEON -4.50%

AEZS -2.49%

AFMD -1.60%

AGEN -2.05%

AGIO -2.25%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 0.61%

AKRO -3.15%

AKTX 1.05%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC 0.69%

ALGS -0.74%

ALKS 0.48%

ALLK -9.32%

ALLO -5.88%

ALLR -0.63%

ALNA 3.16%

ALNY 2.39%

ALPN 0.02%

ALPX 0.00%

ALRN -1.33%

ALT -9.24%

ALVR 2.98%

ALXN 0.00%

ALXO -13.23%

ALZN 5.27%

AMRN -0.46%

AMTI -3.13%

ANAB 1.22%

ANEB -1.52%

ANGN 0.00%

ANIX -1.62%

ANL -6.60%

ANNX -0.22%

ANPC -3.15%

APGE -0.25%

APGN 8.48%

APGNW 30.65%

APLM -2.32%

APLS 0.22%

APLT -3.15%

APM 0.36%

APOP 0.38%

APRE 0.60%

APTO 5.98%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -5.02%

ARDS -14.23%

ARDX 0.00%

ARGX -0.90%

ARNA 0.00%

ARPO -0.90%

ARQT -0.21%

ARTL -2.50%

ARTLW 0.00%

ARVN 5.35%

ARWR -0.82%

ASLN -3.88%

ASMB -5.81%

ASND -1.55%

ATAI -1.85%

ATHA 5.03%

ATHE 0.56%

ATHX -33.50%

ATNF 4.29%

ATOS 2.43%

ATRA -1.93%

ATXI -2.78%

ATXS -0.11%

AUPH -0.90%

AURA 2.79%

AUTL -1.29%

AVBP -1.89%

AVEO 0.00%

AVIR -0.44%

AVRO -1.41%

AVTE -3.47%

AVTX -1.25%

AVXL -3.70%

AXLA 0.00%

AXSM -1.08%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 3.21%

BCAB 5.56%

BCDA -2.23%

BCDAW -41.77%

BCEL 0.00%

BCLI 2.83%

BCRX 0.16%

BCTX 8.90%

BCTXW -16.32%

BCYC 1.15%

BDRX -4.64%

BDTX -1.81%

BEAM 0.99%

BFRA -2.91%

BGNE -2.78%

BIOR -6.15%

BIVI 3.41%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -0.89%

BLTE -0.78%

BLU 0.03%

BLUE 0.58%

BMEA -10.75%

BMRN 0.07%

BNOX 6.22%

BNTC -0.42%

BNTX -1.59%

BOLD -12.19%

BOLT -0.64%

BPMC -1.11%

BPTH 0.00%

BPTS -13.47%

BRNS 0.00%

BRTX -3.52%

BTAI 25.92%

BTTX 50.67%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 4.24%

CABA 1.87%

CADL -1.95%

CALA 0.00%

CALC -1.77%

CALT -1.59%

CAPR -1.72%

CARA -0.06%

CARM 13.97%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS -5.67%

CCCC -5.52%

CCXI 0.00%

CDAK 0.00%

CDIO -2.18%

CDIOW 24.00%

CDMO -2.82%

CDMOP 0.04%

CDT -5.69%

CDTTW -39.60%

CDTX -1.31%

CDXC 0.41%

CDXS 7.24%

CELC -3.94%

CELU -1.00%

CELUW 11.80%

CERC -1.68%

CERE -1.39%

CERO -3.88%

CEROW -21.56%

CFRX -27.95%

CGEM -2.80%

CGEN -3.31%

CGON -1.72%

CGTX -3.98%

CHMA -6.00%

CHRS 1.58%

CINC 0.00%

CING -2.67%

CINGW 34.95%

CKPT -3.81%

CLBS -16.75%

CLDX -1.02%

CLGN 0.34%

CLLS -4.15%

CLNN 0.00%

CLNNW 0.00%

CLRB 6.30%

CLSD 0.00%

CLSN -0.68%

CLVS 0.00%

CMMB -0.98%

CMND 0.00%

CMPI 0.00%

CMPX -1.42%

CMRA 0.00%

CMRAW 33.33%

CMRX -3.47%

CNCE 0.00%

CNSP -36.73%

CNST 0.00%

CNTA -0.28%

CNTB 0.00%

CNTX -7.31%

COCP -2.00%

COEPW 32.45%

COGT -3.07%

CORT 2.73%

COYA -1.46%

CPRX -1.02%

CRBP -3.12%

CRBU -5.97%

CRDF -0.89%

CRGX -0.07%

CRIS -1.72%

CRNX -5.79%

CRSP 0.69%

CRTX 2.63%

CRVO -5.75%

CRVS 1.69%

CSBR -1.59%

CTCX -1.60%

CTIC 0.06%

CTMX -4.12%

CTNM -2.11%

CTXR 2.45%

CUE 6.57%

CVAC -5.23%

CVKD -2.85%

CWBR 2.80%

CYAD -12.96%

CYCC 9.09%

CYCCP 5.49%

CYCN -0.24%

CYT -2.27%

CYTK -2.21%

CYTO -1.82%

DARE 4.02%

DAWN -1.12%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.38%

DNLI -1.25%

DNTH -10.07%

DOMH 2.43%

DRMA -1.68%

DRMAW -1.25%

DRNA 0.00%

DRTS 3.45%

DRTSW 0.00%

DRUG 0.95%

DSGN -2.72%

DTIL 1.99%

DYAI 12.26%

EARS -1.77%

EDIT -2.22%

EDSA 3.19%

EFTR 5.07%

EFTRW -51.85%

EIGR -9.21%

ELAB -2.84%

ELDN 8.99%

ELEV -6.64%

ELOX -5.38%

ELTX -4.26%

ELVN -3.94%

ELYM 2.23%

ENGN -1.72%

ENGNW 0.00%

ENLV 2.90%

ENOB 1.79%

ENSC 3.23%

ENTA 0.08%

ENTO -2.42%

ENTX 1.60%

ENVB 1.58%

EPIX -2.36%

EPRX -1.15%

EPZM 0.00%

EQ 0.34%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.72%

ERNA 0.00%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -3.05%

ETON 1.82%

ETTX 0.00%

EVAX -2.14%

EVGN 4.76%

EVLO 0.00%

EWTX -0.17%

EXAI -1.14%

EXEL 0.11%

EYEG -0.69%

EYEN 1.42%

EYPT 0.48%

FATE -9.81%

FBIO 0.85%

FBIOP -0.37%

FBLG -15.29%

FBRX -0.02%

FDMT -3.34%

FENC -1.05%

FGEN -7.27%

FHTX 6.87%

FIXX 0.77%

FMTX 0.00%

FNCH 8.87%

FOLD -1.97%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE -0.36%

FULC -3.43%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -6.28%

GANX -2.31%

GBIO -2.83%

GBT 0.01%

GDTC 0.50%

GERN -4.44%

GHRS -2.30%

GLMD -4.13%

GLPG -2.15%

GLSI 1.43%

GLTO -2.16%

GLUE -3.17%

GLYC -10.18%

GMAB -0.23%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -3.14%

GNLX -0.22%

GNPX 1.49%

GNTA 3.94%

GOSS -10.58%

GOVX 1.36%

GOVXW -49.04%

GPCR -8.78%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS 1.18%

GRTX 5.14%

GTHX 0.23%

GUTS -5.08%

GXGXW 41.67%

GYRE -8.82%

HALO -1.29%

HARP 0.09%

HCWB -3.75%

HEPA -4.09%

HGEN -84.62%

HILS 5.66%

HLVX 0.15%

HOOK 2.33%

HOTH -3.51%

HOWL -1.71%

HRMY 2.03%

HRTX 4.10%

HSTO 0.00%

HUMA 0.81%

HUMAW -0.01%

IBRX -4.13%

ICCC 0.22%

ICPT 0.21%

ICU 19.34%

ICUCW 20.46%

ICVX -0.91%

IDRA -23.04%

IDYA -1.58%

IFRX -1.54%

IGMS -0.29%

IKNA 0.89%

IKT 0.70%

IMAB 2.33%

IMCR -2.95%

IMGN 0.02%

IMGO 0.00%

IMMP 4.75%

IMMX -7.76%

IMNM 0.82%

IMNN 0.88%

IMPL -27.27%

IMRA 15.96%

IMRN -1.18%

IMRX 0.00%

IMTX -0.79%

IMTXW 6.00%

IMUX 1.85%

IMV 0.00%

IMVT -4.82%

INAB -0.56%

INBX 0.76%

INCY -1.25%

INDP 11.07%

INFI -52.38%

INKT -0.01%

INM 3.14%

INMB 1.68%

INO -1.30%

INSM -1.31%

INTS -2.75%

INVA 0.53%

INZY 0.69%

IOBT -10.67%

IONS 0.68%

IOVA -2.84%

IPA -0.49%

IPHA 5.58%

IPSC -2.54%

IRON -1.89%

ISEE 0.38%

ITOS -1.71%

ITRM 1.67%

IVA 6.96%

IVVD -3.31%

JAGX 1.19%

JANX -3.93%

JAZZ -0.47%

JNCE 0.00%

JSPR -5.84%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -3.54%

KALV -5.11%

KDNY 0.22%

KMPH -0.34%

KNSA -2.06%

KNTE -0.38%

KOD -6.16%

KPRX 0.96%

KPTI -5.05%

KRBP -10.00%

KRON 0.58%

KROS -1.10%

KRRO -8.11%

KRTX 0.03%

KRYS -0.55%

KTRA 9.88%

KTTA -6.79%

KTTAW 0.92%

KURA -0.29%

KYMR -2.76%

KYTX -4.39%

KZIA 2.65%

KZR -0.85%

LABP 0.57%

LBPH -1.52%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.82%

LENZ -4.30%

LEXX -0.38%

LEXXW -14.63%

LGND -0.50%

LGNDV 0.00%

LGVN -7.98%

LIAN -8.28%

LIFE 2.70%

LIPO -3.87%

LIXT -5.24%

LIXTW 63.57%

LJPC -0.32%

LMNL 0.12%

LOGC 1.39%

LPCN -1.86%

LPTX -2.75%

LQDA -0.24%

LRMR -1.92%

LSTA -4.06%

LTRN 1.37%

LUMO -1.32%

LVTX -1.03%

LXEO -2.79%

LXRX -1.76%

LYEL -36.03%

LYRA 1.20%

MACK 0.10%

MBIO -10.02%

MBRX -1.72%

MCRB 3.14%

MDGL -0.89%

MDNA -13.16%

MDWD -0.14%

MDXG -2.80%

MEIP 1.40%

MESO -1.41%

MGNX -2.34%

MGTA -7.74%

MGTX -3.61%

MGX -4.02%

MIRM -1.03%

MIRO 0.59%

MIST 1.15%

MITO 0.00%

MLEC -7.69%

MLECW 2.31%

MLND -5.36%

MLTX 0.56%

MLYS -7.37%

MNKD 0.29%

MNMD -0.07%

MNOV 2.11%

MNPR -8.52%

MOLN 1.79%

MOR 1.20%

MORF -3.22%

MREO -2.29%

MRKR 2.57%

MRNA -5.85%

MRNS -4.04%

MRSN -2.38%

MRTX -0.17%

MRUS 0.27%

MRVI -1.24%

MTCR -1.29%

MTEM 4.46%

MTP -18.50%

MURA -0.93%

MYMD 5.77%

NAMS 3.33%

NAMSW -0.21%

NAUT 1.55%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.73%

NERV -0.63%

NEXI 4.04%

NGM -1.28%

NGNE -1.41%

NKGN 10.08%

NKGNW 8.00%

NKTR -3.76%

NKTX -4.99%

NLSP 5.91%

NLSPW 26.67%

NMRA -2.86%

NMTR -42.97%

NOVN -24.84%

NRBO 10.40%

NRIX -2.12%

NRSN -5.12%

NRSNW 0.00%

NRXP -3.72%

NRXPW 18.33%

NRXS 4.82%

NTBL 3.42%

NTEC -12.45%

NTHI 0.00%

NTLA -6.67%

NTRBW -31.07%

NUVL -1.61%

NVAX -2.29%

NVCT 3.55%

NVIV -34.28%

NXTC -2.94%

NYMX -0.05%

OABI 1.45%

OABIW -10.06%

OBIO -3.07%

OBSV 0.00%

OCEA 0.00%

OCGN 2.97%

OCS -1.00%

OCUL -0.23%

OCUP 1.84%

ODT -4.27%

OKYO 1.51%

OLMA -5.28%

OMER -1.03%

OMGA 5.63%

ONCO 4.54%

ONCR -3.08%

ONCS 31.87%

ONCT -3.05%

ONCY 1.49%

ONTX -0.47%

ONVO 0.47%

OPNT 0.00%

OPT 3.09%

ORGS 0.96%

ORIC -3.42%

ORMP 18.30%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -2.22%

OVID 0.51%

OYST 0.00%

PALI 1.30%

PASG -1.30%

PBLA -7.50%

PBM -3.48%

PBYI 1.52%

PCSA 0.00%

PCVX -0.21%

PDSB -3.50%

PEPG 0.78%

PGEN -2.99%

PHAR 1.51%

PHAS 0.00%

PHAT -1.06%

PHIO -3.47%

PHIOW 36.47%

PHVS -7.32%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -1.33%

PLUR 7.39%

PMN 0.72%

PMVP -0.30%

PNT 0.16%

PPBT -5.53%

PRAX 3.06%

PRDS 0.93%

PRLD -2.37%

PROG -3.47%

PROK 0.00%

PRQR -0.66%

PRTA -2.46%

PRTC 0.49%

PRTG 7.02%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -10.46%

PSTX -1.36%

PTCT -0.26%

PTE -0.82%

PTGX -0.73%

PTIXW -48.41%

PULM 2.60%

PXMD 4.76%

PYPD 0.07%

PYXS 1.14%

QLGN -3.00%

QNCX 5.70%

QNRX -1.14%

QSI -11.54%

QSIAW -3.13%

QTTB -3.45%

QURE -0.78%

RAIN -1.63%

RANI 6.42%

RAPT -1.30%

RARE 1.44%

RCKT -8.64%

REGN 0.20%

RENB -3.42%

REPL -2.15%

RETA 0.02%

REUN -0.89%

REVB -2.79%

REVBU 3.46%

REVBW 4.38%

RGLS -6.78%

RGNX -5.88%

RIGL -3.28%

RLAY -3.86%

RLMD 0.35%

RLYB -1.34%

RNA 0.92%

RNAC -2.94%

RNAZ -1.90%

RNXT 0.89%

ROIV -2.08%

ROIVW 4.56%

RPHM -0.62%

RPRX 0.30%

RPTX 0.15%

RUBY 2.70%

RVLP -32.05%

RVMD -0.98%

RVMDW -30.00%

RVNC 0.21%

RVPH -0.79%

RVPHW 1.62%

RXDX 0.09%

RXRX -4.53%

RYTM -5.61%

RYZB 0.02%

RZLT 3.36%

SABS -1.37%

SABSW -11.81%

SAGE 1.47%

SANA -3.60%

SAVA -0.16%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -0.06%

SCPH 5.30%

SCPS 0.00%

SEEL -8.18%

SEER 0.29%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -0.38%

SGMT -2.41%

SGTX -2.56%

SIOX 22.63%

SLDB -8.97%

SLGL 4.12%

SLN -4.57%

SLNO -4.58%

SLRX 5.26%

SLS -1.71%

SMMT -1.62%

SNDX 1.33%

SNGX -4.91%

SNPX -4.44%

SONN 0.00%

SPPI -0.49%

SPRB 0.63%

SPRC -2.75%

SPRO 0.05%

SRNE -34.00%

SRPT -1.00%

SRRA 0.00%

SRRK -2.23%

SRZN -2.45%

STAB 0.00%

STOK -5.52%

STRO -3.51%

STSA 0.00%

STTK -1.69%

SURF -0.93%

SVRA -7.23%

SWTX -0.33%

SYBX -1.29%

SYRS -1.55%

TALS -0.73%

TARA -7.62%

TARS 0.27%

TBPH 0.48%

TCBP 2.48%

TCDA 0.00%

TCON 2.46%

TCRR 0.00%

TCRT 0.08%

TCRX -1.05%

TECH -0.22%

TENX 1.91%

TERN -8.28%

TFFP -5.33%

TGTX -4.33%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -4.60%

TNGX -3.66%

TNXP -6.00%

TNYA -4.56%

TPST 4.88%

TRDA -4.06%

TRVI 2.30%

TRVN 1.60%

TSHA -22.92%

TSVT -3.46%

TTNP -7.66%

TVTX 1.26%

TYRA -8.49%

UBX -2.48%

UNCY -4.00%

URGN -1.15%

UTHR 0.61%

VACC 11.36%

VALN -4.07%

VAXX 100.00%

VBIV 0.33%

VBLT -8.77%

VCEL 0.96%

VCNX 10.35%

VCYT -1.45%

VERA -3.92%

VERU 0.97%

VERV -2.96%

VIGL 4.84%

VINC 2.28%

VIR 1.03%

VIRI -1.85%

VIRX 3.15%

VKTX -1.26%

VLON -13.04%

VNDA -3.50%

VOR -1.62%

VRCA 0.00%

VRDN -4.39%

VRNA -0.47%

VRPX 0.38%

VRTX 0.32%

VSTM -0.85%

VTGN -0.45%

VTVT -2.97%

VTYX -1.05%

VXRT -4.59%

VYGR 0.00%

VYNE -4.62%

VYNT 7.78%

WINT 2.18%

WVE -6.08%

XBIO 1.03%

XBIT -2.09%

XCUR 3.55%

XENE -1.35%

XERS 2.62%

XFOR 5.00%

XLO 3.94%

XLRN 0.00%

XNCR 0.52%

XOMA -3.34%

XOMAO -0.16%

XOMAP -0.82%

XRTX -8.00%

YMAB -1.59%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.70%

ZNTL -2.38%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2023-03-23	Klassen Preston	Sell	842 211	Common Stock
2023-03-23	Klassen Preston	Sell	842 211	Stock Option (right to buy)
2023-01-26	York Michael	Sell	107 054	Common Stock
2023-01-26	Klassen Preston	Sell	380 605	Common Stock
2022-12-21	Leonard Braden Michael	Buy	120 099	Common Stock

INSIDER POWER
-23.62
Last 97 transactions
Buy: 12 877 287 \| Sell: 12 262 808

音量相关性

長: -0.64 (weak negative)

短: 0.81 (strong)

Signal:(57.111) Same movement expected

Metacrine, Inc. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Metacrine, Inc. 相关性 - 货币/商品

-0.11
( neutral )

0.24
( neutral )

0.00
( neutral )

-0.32
( neutral )

Metacrine, Inc. 财务报表

Annual	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-2.40

FY	2021
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-2.40

FY	2020
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.436

FY	2019
营收:	$0.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.520

Financial Reports:

No articles found.

Metacrine, Inc. Dividends

(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0.580 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Metacrine, Inc. Dividend Information - Dividend Knight

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.580	2023-06-21
Last Dividend	$0.580	2023-06-21
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.580	--
Avg. Dividend % Per Year	43.27%	--
Score	4.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-06-26)

$1.160 Estimate 2.50 %

Dividend Stability

0.20 Very Poor

Dividend Score

4.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2023	$0.580	129.80%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
21 Jun 2023	$0.580	30 Nov -0001	30 Nov -0001	30 Nov -0001

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2024-09-16	Monthly	14	15.03%	9.60
DMLP	Dividend Diamond	2024-04-26	Quarterly	22	10.71%	9.35
OXSQ	Dividend Diamond	2024-09-16	Monthly	21	12.73%	9.02
ARLP	Dividend Royal	2024-05-07	Quarterly	26	9.67%	8.87
PNNT	Dividend Royal	2024-06-14	Monthly	18	9.49%	8.82
MFIC	Dividend Royal	2024-06-11	Quarterly	21	10.89%	8.79
SPOK	Dividend Royal	2024-05-23	Quarterly	20	8.73%	8.72
PSEC	Dividend Royal	2024-06-25	Monthly	21	9.03%	8.65
SBLK	Dividend Royal	2024-06-06	Quarterly	17	13.10%	8.63
GBDC	Dividend Royal	2024-11-29	Bi-Monthly	15	8.53%	8.62

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	-0.766	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.835	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	10.15	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	13.40	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	9.85	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.177	-1.500	7.06	-10.00	[0 - 0.6]
interestCoverageTTM	-50.81	1.000	-10.00	-10.00	[3 - 30]
operatingCashFlowPerShareTTM	-1.120	2.00	-0.373	-0.747	[0 - 30]
freeCashFlowPerShareTTM	-1.120	2.00	-0.560	-1.120	[0 - 20]
debtEquityRatioTTM	0.246	-1.500	9.01	-10.00	[0 - 2.5]
grossProfitMarginTTM	0	1.000	-3.33	-3.33	[0.2 - 0.8]
operatingProfitMarginTTM	0	1.000	-2.00	-2.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-3.34	1.000	-10.00	-10.00	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.578

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.400	1.000	-0.141	0	[1 - 100]
returnOnEquityTTM	-0.835	2.50	-6.68	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-1.120	2.00	-0.373	-1.120	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.120	2.00	-0.373	-0.747	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.00400	1.500	-3.36	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				-1.917

Metacrine, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Metacrine, Inc.

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.